Article

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.

2020-04-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold> CSF from unique groups of Parkinson’s disease (PD) patients were biochemically profiled to identify previously unreported metabolic pathways linked to PD pathogenesis and novel biochemical biomarkers of the disease were characterized. <bold>Methods:</bold> Utilizing both <sup>1</sup>H NMR and DI-LC-MS/MS we quantitatively profiled CSF from patients with sporadi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d0e67732-22c7-5128-8c98-74094d3a87a4
DOI: 10.21203/rs.3.rs-20742/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.DOI 10.21203/rs.3.rs-20742/v1Read

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.Semantic proximity Read

Sex differences impact serum metabolome profiles in patients with familial Parkinson’s diseaseSemantic proximity Read

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity Read

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read

Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidSemantic proximity Read

Untargeted <sup>1</sup> H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtypeSemantic proximity Read

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker DiscoverySemantic proximity Read

Mutations in the <i>GBA1</i> , <i>LRRK2</i> , <i>TMEM175</i> , <i>PARK2</i> , <i>PINK1</i> , and <i>PARK7</i> genes lead to sex-specific serum metabolic changes in patients with Parkinson’s diseaseSemantic proximity Read

Discovery of Sexual Dimorphism in the Serum Metabolome of Parkinson’s Disease Patients Harboring Rare Genetic Variants with Uncertain PathogenicitySemantic proximity Read

Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with monogenic and idiopathic Parkinson’s diseaseSemantic proximity Read

Cerebrospinal Fluid and Plasma Metabolites with Parkinson’s Disease: A Mendelian Randomization StudySemantic proximity Read

Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity Read